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Staphylococcus aureus isolated from skin and soft
tissue infections in relation to staphylococcal
cassette chromosome type
We read with interest the paper entitled ‘‘Characterization of
methicillin-resistant Staphylococcus aureus from skin and soft
tissue infections in patients in Nairobi, Kenya’’ by Maina et al.1
Methicillin-resistant Staphylococcus aureus (MRSA) was detected
using oxacillin resistance screening agar, cefoxitin disk, and a
penicillin binding protein 2a (PBP2a) latex agglutination test kit
(Denka Seiken). Those strains that showed a discrepancy between
the phenotypic result and PBP2a latex agglutination test result
were further tested for the presence of the mecA gene. The authors
reported an MRSA prevalence rate of 84.1% among isolates of S.
aureus recovered from skin and soft tissue infections (SSTIs). Out of
these MRSA, 75.4% possessed staphylococcal cassette chromosome
mec (SCCmec) type II and 20.3% were positive for the Panton–
Valentine leukocidin (PVL) gene. Additionally all MRSA strains
were susceptible to vancomycin by disk diffusion method.
However, we have certain reservations regarding the discrep-
ancy between various phenotypic methods for MRSA detection, the
method of phenotypic detection of vancomycin susceptibility, and
the relationship between SCC typing and characteristics of these
MRSA strains.
Various phenotypic methods for the detection of MRSA have
varying sensitivity. In our study, the oxacillin screening agar had a
sensitivity of 97.1%, cefoxitin disk diffusion had a sensitivity of
98.5%, and latex agglutination for PBP2a detection had a sensitivity
of 100%, when PCR for mecA gene detection was taken as the gold
standard, leading to reservations regarding the phenotypic
methods for MRSA detection.2 The need of the hour is a cheap,
rapid, phenotypic test that can detect MRSA with high sensitivity
and speciﬁcity. The needless use of a reserve drug like vancomycin
or linezolid in cases with false-positive results will lead to more
drug resistance and increases in health care costs, while false-
negative reports of MRSA will lead to treatment failure and
increased nosocomial and community spread of this deadly
microbe.
The Clinical and Laboratory Standards Institute (CLSI) recom-
mends performing minimum inhibitory concentration (MIC)
testing for the detection of susceptibility to vancomycin for all1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.04.014isolates. The disk diffusion test does not differentiate between
vancomycin-susceptible isolates of S. aureus and vancomycin-
intermediate strains of S. aureus.3
SCCmec is a mobile genetic element that carries resistance to
methicillin and other beta-lactam antibiotics, caused by the mecA
gene. Five SCCmec types (I–V) have been distinguished. Addition-
ally, SCCmec types II and III carry non-beta-lactam antibiotic
resistance genes. Community MRSA (CA-MRSA) is both phenotyp-
ically and genotypically different from healthcare-associated
MRSA (HA-MRSA). CA-MRSA harbors SCCmec types IV or V and
is associated with the genes encoding PVL.4
In the light of these considerations, could this high rate of
vancomycin susceptibility be due to the use of disk diffusion
instead of MIC, as recommended by CLSI? Were there any
discrepancies in the reporting of MRSA by the various different
phenotypic methods? Did the authors look for a genotypic
relationship between the different strains, as both inpatients
and outpatients were included in the study?
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